Thursday, June 18, 2026
RESI San Diego pharmaceutical event banner
← Back to Events
Tier 1 Global Networking: High BIOTECH 4 DAYS AWAY

RESI San Diego — 2026 — JULEP Venue San Diego, San Diego, USA

RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29. This hybrid format combines the benefits of in-person networking with the flexibility of on

JULEP Venue San Diego, San Diego, USA June 22 – June 23, 2026
300+ Attendees
6 Presentations
5 Companies
1 Drugs
All Events

Presentation data updated Jun 5, 2026, 11:28 AM UTC

Why This Event Matters

RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29.

Industry impact

RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29.

Market implications

Expect signals on pricing, formulary strategy, and partnership economics relevant to biotech markets in the US region.

Regulatory implications

FDA and CMS policy discussions around evidence generation, 340B, and real-world data often surface at biotech leadership forums.

Investor implications

Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from RESI San Diego.

Competitive implications

Competitive positioning among top biotech players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.

Event Significance

Tier-1 industry catalyst

48 /100 composite

RESI San Diego is a targeted biotech forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: speaker calibre and KOL density.

  • Media coverage 10/20

    Moderate coverage; Nova editorial will prioritize confirmed data releases.

  • Speaker quality 14/20

    Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.

  • Pipeline relevance 1/20

    Early science or services-focused — lower near-term PDUFA linkage.

  • Historical influence 13/20

    Some historical catalysts; compare readouts against last cycle.

  • Company participation 10/20

    Meaningful sponsor footprint; BD teams can pre-book partnering slots.

Nova Pharma Intelligence · Analyst desk

Key Takeaways

  • Watch oral (Immunic, Inc.): Top-line Data Readout of the Twin Phase 3 ENSURE Trials
  • Immunic, Inc. carries 1 tracked presentations — map against peer readouts at RESI San Diego.
  • Fractyl Health carries 2 tracked presentations — map against peer readouts at RESI San Diego.
  • Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from RESI San Diego.
  • FDA and CMS policy discussions around evidence generation, 340B, and real-world data often surface at biotech leadership forums.
  • rese-cel (Cabaletta Bio) — 1 data points on the schedule.

Timeline & Milestones

  1. Pre-event intelligence In progress

    6 presentations tracked — Key Data and Companies hubs live.

  2. Conference opens Jun 22, 2026 Upcoming

    Live readouts, late-breakers, and partnership announcements.

  3. Live coverage window Upcoming

    1 Nova articles linked — see Coverage & Analysis.

  4. Conference closes Jun 23, 2026 Upcoming

    Post-event recap, competitive takeaways, and trial updates.

Best for
Investors & analysts

Executive Summary

C-level brief

RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29.

Primary audience: Investors & analysts

Analyst Watch

Investor desk

Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from RESI San Diego.

Regulatory affairs

FDA and CMS policy discussions around evidence generation, 340B, and real-world data often surface at biotech leadership forums.

Competitive intelligence

Competitive positioning among top biotech players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.

vs. Prior Editions

Edition Presentations Companies
RESI San Diego (current) 6 5
RESI Boston 2026 (2026) 0 0

Most Anticipated Presentations

Full data hub →
ORAL Jun 22

Top-line Data Readout of the Twin Phase 3 ENSURE Trials

Immunic, Inc.$IMUX Phase Iii Multiple Sclerosis
INVESTOR IMPACT: ★★★★☆ 4/5
ORAL Jun 22

1-Year Data from the REVEAL-1 Cohort of Revita

Fractyl Health$GUTS Phase Ii Type 2 Diabetes / Obesity
INVESTOR IMPACT: ★★☆☆☆ 2/5
ORAL Jun 23

1-Year Randomized Data from the REMAIN-1 Midpoint Cohort of Revita

Fractyl Health$GUTS Phase Ii Type 2 Diabetes / Obesity
INVESTOR IMPACT: ★★☆☆☆ 2/5
POSTER Jun 22

New Rese-cel Data in Dermatomyositis: 83% of Patients Would Have Met Registrational Primary Endpoint

Cabaletta Bio$CABA rese-cel Phase I Dermatomyositis
INVESTOR IMPACT: ★☆☆☆☆ 1/5
ORAL Jun 22

Initial Clinical Data from Sutro Biopharma Pipeline

Sutro Biopharma$STRO Phase I Cancer
INVESTOR IMPACT: ★☆☆☆☆ 1/5
POSTER Jun 23

Randomized EXALT-2 Trial: Clinical Utility and Health Outcomes

INVESTOR IMPACT: ★☆☆☆☆ 1/5

Competitive Landscape

Company map →

Competitive positioning among top biotech players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.

Companies to Watch

All companies →

Drug Pipelines to Watch

Pipeline data →

Coverage & Analysis

No coverage articles yet. Check back closer to the event.

Related News & Research

Research hub →

Event Intelligence Summary

Standalone summaries for RESI San Diego — optimized for research and AI retrieval.

Executive Summary

RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29.

Analyst View

RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25,28-29.

Investor View

Investors should track partnership announcements, pipeline prioritization signals, and vendor consolidation themes emerging from RESI San Diego.

BD View

BD teams should prioritize networking with presenting companies and services vendors at RESI San Diego, focusing on biotech partnership and licensing opportunities.

Key Facts

Event
RESI San Diego
Focus
biotech
Region
US Americas
Attendance
300+

Ask Nova AI

AI-assisted answers grounded in NovaPharmaNews intelligence

Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.

Frequently Asked Questions

What is RESI San Diego?

RESI San Diego is a biotech industry conference bringing together executives, clinical leaders, and investors to discuss pipeline, regulatory, and commercial strategy.

Who attends RESI San Diego?

Typical attendees include pharma executives, BD teams, investors, regulatory affairs professionals, and clinical operations leaders focused on biotech.

Why is RESI San Diego important?

RESI San Diego influences partnership timing, pipeline prioritization, and policy debates that affect biotech markets for the next 12–18 months.

When is RESI San Diego?

RESI San Diego takes place on the scheduled dates.

Where is RESI San Diego held?

RESI San Diego is held in the listed venue.

How many attendees does RESI San Diego attract?

RESI San Diego typically draws 300+ attendees from across the biotech ecosystem.

What companies participate at RESI San Diego?

5+ companies present data or participate in programming at RESI San Diego, spanning large pharma, biotech, and services vendors.

What should investors watch at RESI San Diego?

Investors should track partnership announcements, pipeline readouts, M&A signals, and management commentary on biotech catalysts during and after RESI San Diego.

What BD opportunities exist at RESI San Diego?

BD teams use RESI San Diego for licensing discussions, co-development talks, and vendor selection across biotech — especially in networking sessions and satellite meetings.

How does RESI San Diego compare with other pharma conferences?

RESI San Diego is a tier-1 global congress for biotech — compare speaker quality, company participation, and historical deal flow with peer events in the same therapeutic or commercial vertical.

How do I get NovaPharmaNews coverage of RESI San Diego?

NovaPharmaNews publishes pre-event briefs, live coverage, and post-event analysis for RESI San Diego. Subscribe to event alerts on this page for breaking updates.

Intelligence Navigation